"It's said to be the most common cause of preventable death of patients in hospital but in New Zealand particularly, we are dragging the chain and we are behind in what should be a careful approach to treating these people ... preventing it from happening," he said.
After taking action from an audit in 2007/08, Tauranga Hospital is one of the country's leading hospital's in taking preventative VTE action. But efforts have been hampered by a lack of awareness from patients, Dr Graham said.
"The people behind it are driving it but there's the other side, the consumer, and consumer awareness is quite limited at the moment."
Dr Graham said there was a "steep rise" in the risks of VTE happening as people got older, which was pertinent in Tauranga because of the region's ageing population.
"If you're an older person who had a heart attack or stroke and then your chances are pretty high of getting a clot to your legs or lungs if you are a patient in hospital."
People who have had surgery to their abdomen, pelvic and leg area were also more prone to clots in the post-operative period.
"Sometimes people die when they go home. They have an operation and a week later they drop dead and often doctors don't hear about those people," Dr Graham said.
Simple measures to help prevent VTE involve gentle activity after surgery, keeping hydrated and taking medication to help thin the blood.
"People are aware when they get on to a plane of a risk of a clot forming in their legs," Dr Graham said.
"There's a much greater risk of dying from VTE if you are a 65-year-old having major pelvic surgery than if you went to London on a plane."
While data was not available for New Zealand, Australian statistics showed 60 per cent of cancer patients in hospital will get clots to the legs or lungs and about 50 per cent of stroke patients.
In 2008, there were 5285 deaths from VTE.
In the United Kingdom the rates were similar. Each year more than 25,000 people in England are thought to die from VTE contracted in hospital. This is more than the combined total of deaths from breast cancer, AIDS and traffic accidents and more than 25 times the number of deaths from MRSA (methicillin-resistant staphylococcus aureus), Dr Graham said.
"What is happening in the UK and Australia in regard to prevention of VTE in patients is not happening as much in New Zealand," he said.
"In Tauranga, we are a long way ahead of some other hospitals [in New Zealand]. A lot of hospitals have not done much."
Dr Graham advised people being admitted to hospital anywhere to ensure the VTE risks and prevention measures were explained to them.